{"id":"c1948b2c-8487-4b0c-abb7-7dd5972423cf","kind":"companies","code":"UB-C8545","name":"Rivercell","nameBasis":"source-english","summary":"Rivercell is a company headquartered in Paris, France.","description":"","country":"France","category":null,"originalName":"Rivercell","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-15T17:11:37.880Z","reviewedAt":"2026-10-15T17:11:37.880Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e55c4817202be8d9649d0d1dc1e3579ae0142f96bda3f3692744ad4546a986eb","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"1997c6fb-0047-4be4-a6fb-8cd846d98202","kind":"institutions","code":"UB-I563","name":"HV Capital","nameBasis":"original-brand","summary":"HV Capital, a European early-stage venture capital firm focused on seed- and startup-round companies.","description":"HV Capital, a European early-stage venture capital firm focused on seed- and startup-round companies.","country":null,"category":null,"originalName":"HV Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.619Z","englishUpdatedAt":"2026-10-15T21:39:21.105Z","reviewedAt":"2026-10-15T21:39:21.105Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"970bb7f903a062eae166033cf503d86d3836d2c4c5923117d47b3fed80706af3","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hv-capital"},{"id":"1957021d-5b50-4477-acb6-5eaa548d29ad","kind":"news","code":"1957021d-5b50-4477-acb6-5eaa548d29ad","name":"Rivercell raises USD 25 million to build AI virtual cells and accelerate drug discovery","nameBasis":"translated-title","summary":"According to European Biotechnology, Rivercell raised USD 25 million on 10/7, led by HV Capital. It is building AI virtual cell models to digitalize key validation stages of drug discovery, aiming to shorten new drug development cycles and reduce early trial-and-error costs.","description":"","country":null,"category":null,"originalName":"Rivercell完成2500万美元融资，构建AI虚拟细胞加速药物发现","eventDate":"2026-10-07T00:00:00.000Z","website":"https://european-biotechnology.com/latest-news/rivercell-raises-25m-to-build-an-ai-virtual-cell/","sourceUpdatedAt":"2026-10-17T23:00:17.514Z","englishUpdatedAt":"2026-10-18T08:52:14.023Z","reviewedAt":"2026-10-18T08:52:14.023Z","snapshotAt":"2026-10-18T08:51:49.337Z","sourceHash":"34cccd8cbd58c1fabb27c809001680ddd84b24baaaefdeae50122580c05c78ae","companyId":"c1948b2c-8487-4b0c-abb7-7dd5972423cf","foundedYear":null,"logoUrl":null,"path":"/news/1957021d-5b50-4477-acb6-5eaa548d29ad"}],"finance":{"funding":{"metric":"funding","count":1,"latest":{"value":25000000,"text":"2500万美元（$25M）","date":"2026-10-07T00:00:00.000Z","round":null,"estimate":"$25M"},"years":[2026],"points":[{"year":2026,"date":"2026-10-07T00:00:00.000Z","round":null,"value":25000000,"eventIds":["1957021d-5b50-4477-acb6-5eaa548d29ad"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"1957021d-5b50-4477-acb6-5eaa548d29ad","date":"2026-10-07T00:00:00.000Z","round":null,"amountText":"2500万美元（$25M）","estimateUsd":25000000,"estimateLabel":"$25M","estimateNote":null,"investors":"HV Capital","institutions":[{"id":"1997c6fb-0047-4be4-a6fb-8cd846d98202","kind":"institutions","code":"UB-I563","name":"HV Capital","nameBasis":"original-brand","summary":"HV Capital, a European early-stage venture capital firm focused on seed- and startup-round companies.","description":"HV Capital, a European early-stage venture capital firm focused on seed- and startup-round companies.","country":null,"category":null,"originalName":"HV Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.619Z","englishUpdatedAt":"2026-10-15T21:39:21.105Z","reviewedAt":"2026-10-15T21:39:21.105Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"970bb7f903a062eae166033cf503d86d3836d2c4c5923117d47b3fed80706af3","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hv-capital"}],"newsUrl":"https://european-biotechnology.com/latest-news/rivercell-raises-25m-to-build-an-ai-virtual-cell/","evidence":{"headline":"Rivercell raises USD 25 million to build AI virtual cells and accelerate drug discovery","brief":"According to European Biotechnology, Rivercell raised USD 25 million on 10/7, led by HV Capital. It is building AI virtual cell models to digitalize key validation stages of drug discovery, aiming to shorten new drug development cycles and reduce early trial-and-error costs.","basis":"translated-source-brief","newsPath":"/news/1957021d-5b50-4477-acb6-5eaa548d29ad","sourceCount":1}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"1957021d-5b50-4477-acb6-5eaa548d29ad","date":"2026-10-07T00:00:00.000Z","round":null,"amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"HV Capital","institutions":[{"id":"1997c6fb-0047-4be4-a6fb-8cd846d98202","kind":"institutions","code":"UB-I563","name":"HV Capital","nameBasis":"original-brand","summary":"HV Capital, a European early-stage venture capital firm focused on seed- and startup-round companies.","description":"HV Capital, a European early-stage venture capital firm focused on seed- and startup-round companies.","country":null,"category":null,"originalName":"HV Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.619Z","englishUpdatedAt":"2026-10-15T21:39:21.105Z","reviewedAt":"2026-10-15T21:39:21.105Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"970bb7f903a062eae166033cf503d86d3836d2c4c5923117d47b3fed80706af3","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hv-capital"}],"newsUrl":"https://european-biotechnology.com/latest-news/rivercell-raises-25m-to-build-an-ai-virtual-cell/","evidence":{"headline":"Rivercell raises USD 25 million to build AI virtual cells and accelerate drug discovery","brief":"According to European Biotechnology, Rivercell raised USD 25 million on 10/7, led by HV Capital. It is building AI virtual cell models to digitalize key validation stages of drug discovery, aiming to shorten new drug development cycles and reduce early trial-and-error costs.","basis":"translated-source-brief","newsPath":"/news/1957021d-5b50-4477-acb6-5eaa548d29ad","sourceCount":1}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"1957021d-5b50-4477-acb6-5eaa548d29ad","kind":"funding","eventDate":"2026-10-07T00:00:00.000Z","revenueDate":null,"round":null,"amountText":"2500万美元（$25M）","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":25000000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"HV Capital","newsUrl":"https://european-biotechnology.com/latest-news/rivercell-raises-25m-to-build-an-ai-virtual-cell/","newsTypes":["融资"],"institutions":[{"id":"1997c6fb-0047-4be4-a6fb-8cd846d98202","kind":"institutions","code":"UB-I563","name":"HV Capital","nameBasis":"original-brand","summary":"HV Capital, a European early-stage venture capital firm focused on seed- and startup-round companies.","description":"HV Capital, a European early-stage venture capital firm focused on seed- and startup-round companies.","country":null,"category":null,"originalName":"HV Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.619Z","englishUpdatedAt":"2026-10-15T21:39:21.105Z","reviewedAt":"2026-10-15T21:39:21.105Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"970bb7f903a062eae166033cf503d86d3836d2c4c5923117d47b3fed80706af3","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hv-capital"}],"roundName":null,"amountLabel":"$25M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"1997c6fb-0047-4be4-a6fb-8cd846d98202","kind":"institutions","code":"UB-I563","name":"HV Capital","nameBasis":"original-brand","summary":"HV Capital, a European early-stage venture capital firm focused on seed- and startup-round companies.","description":"HV Capital, a European early-stage venture capital firm focused on seed- and startup-round companies.","country":null,"category":null,"originalName":"HV Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.619Z","englishUpdatedAt":"2026-10-15T21:39:21.105Z","reviewedAt":"2026-10-15T21:39:21.105Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"970bb7f903a062eae166033cf503d86d3836d2c4c5923117d47b3fed80706af3","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hv-capital"}],"path":"/companies/rivercell","structured":{"city":"Paris","country":"France","location":null,"role":null,"category":null,"company":null},"definition":"Rivercell is a company headquartered in Paris, France.","summaryBasis":"generated","thin":false,"canonical":"https://uniquebase.ai/companies/rivercell"}